10x Genomics (TXG) Misses Q4 EPS by 9c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
10X Genomics (TXG) PT Lowered to $20 at Citi
February 13, 2025 6:40 AM ESTCiti analyst Patrick Donnelly lowered the price target on 10X Genomics (NASDAQ: TXG) to $20.00 (from $23.00) while maintaining a Buy rating.
The analyst comments "After pre-announcing last month, TXG reported official 4Q revenue of $165mn, above FactSet consensus of ~$160mn and the... More
